Adipose-derived stromal/stem cells improve epidermal homeostasis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 12 2019
Historique:
received: 21 05 2019
accepted: 19 11 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

Wound healing is regulated by complex interactions between the keratinocytes and other cell types including fibroblasts. Recently, adipose-derived mesenchymal stromal/stem cells (ASCs) have been reported to influence wound healing positively via paracrine involvement. However, their roles in keratinocytes are still obscure. Therefore, investigation of the precise effects of ASCs on keratinocytes in an in vitro culture system is required. Our recent data indicate that the epidermal equivalents became thicker on a collagen vitrigel membrane co-cultured with human ASCs (hASCs). Co-culturing the human primary epidermal keratinocytes (HPEK) with hASCs on a collagen vitrigel membrane enhanced their abilities for cell proliferation and adhesion to the membrane but suppressed their differentiation suggesting that hASCs could maintain the undifferentiated status of HPEK. Contrarily, the effects of co-culture using polyethylene terephthalate or polycarbonate membranes for HPEK were completely opposite. These differences may depend on the protein permeability and/or structure of the membrane. Taken together, our data demonstrate that hASCs could be used as a substitute for fibroblasts in skin wound repair, aesthetic medicine, or tissue engineering. It is also important to note that a co-culture system using the collagen vitrigel membrane allows better understanding of the interactions between the keratinocytes and ASCs.

Identifiants

pubmed: 31797970
doi: 10.1038/s41598-019-54797-5
pii: 10.1038/s41598-019-54797-5
pmc: PMC6892794
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18371

Références

Burns. 1992;18 Suppl 1:S11-6
pubmed: 1554417
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Nat Cell Biol. 2001 Sep;3(9):778-84
pubmed: 11533656
Stem Cells Dev. 2005 Jun;14(3):337-48
pubmed: 15969629
Int J Cosmet Sci. 2013 Oct;35(5):448-57
pubmed: 23651429
Adv Exp Med Biol. 2018;1119:133-149
pubmed: 29858972
BMC Cell Biol. 2012 Aug 07;13:21
pubmed: 22870983
Vasc Cell. 2011 Feb 08;3(1):5
pubmed: 21349162
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
PLoS One. 2013 Jun 12;8(6):e66274
pubmed: 23776652
Stem Cells Int. 2016;2016:3658798
pubmed: 27239202
Sex Med. 2013 Aug;1(1):3-15
pubmed: 25356281
Methods Mol Biol. 2009;522:203-10
pubmed: 19247616
J Transl Med. 2018 Jul 27;16(1):212
pubmed: 30053821
Stem Cells Dev. 2014 Sep 15;23(18):2211-24
pubmed: 24878247
J Tissue Eng. 2017 Aug 18;8:2041731417724640
pubmed: 29081966
J Cell Sci. 2007 Aug 15;120(Pt 16):2875-83
pubmed: 17652163
Cell Transplant. 2004;13(4):463-73
pubmed: 15468688
Yakugaku Zasshi. 2010 Apr;130(4):565-74
pubmed: 20372002
J Cell Biol. 2006 May 8;173(3):333-9
pubmed: 16651378
Acta Haematol. 2016;136(2):85-97
pubmed: 27188909
Cells Tissues Organs. 2007;185(1-3):237-41
pubmed: 17587830
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):113-9
pubmed: 18172082
Wound Repair Regen. 2013 Sep-Oct;21(5):746-54
pubmed: 23937682
Plast Reconstr Surg Glob Open. 2015 Apr 07;3(3):e334
pubmed: 25878945
PLoS One. 2013;8(1):e55640
pubmed: 23383253
Stem Cells. 2008 Oct;26(10):2713-23
pubmed: 18617689
Cell. 1975 Nov;6(3):331-43
pubmed: 1052771
Exp Dermatol. 2008 Nov;17(11):925-32
pubmed: 18557932
Ann Dermatol. 2012 May;24(2):136-43
pubmed: 22577262
PLoS One. 2012;7(7):e40951
pubmed: 22911722
J Cell Physiol. 1991 Oct;149(1):110-6
pubmed: 1939339
J Dermatol Sci. 2016 May;82(2):84-94
pubmed: 26867959

Auteurs

Mariko Moriyama (M)

Pharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, 577-8502, Japan.

Shunya Sahara (S)

Research and Development Division, PIAS Corporation, Kobe, Hyogo, 651-2241, Japan.

Kaori Zaiki (K)

Research and Development Division, PIAS Corporation, Kobe, Hyogo, 651-2241, Japan.

Ayumi Ueno (A)

Research and Development Division, PIAS Corporation, Kobe, Hyogo, 651-2241, Japan.

Koichi Nakaoji (K)

Research and Development Division, PIAS Corporation, Kobe, Hyogo, 651-2241, Japan.

Kazuhiko Hamada (K)

Research and Development Division, PIAS Corporation, Kobe, Hyogo, 651-2241, Japan.

Toshiyuki Ozawa (T)

Department of Dermatology, Graduate School of Medicine, Osaka City University, Abeno-Ku, Osaka, 545-8585, Japan.

Daisuke Tsuruta (D)

Department of Dermatology, Graduate School of Medicine, Osaka City University, Abeno-Ku, Osaka, 545-8585, Japan.

Takao Hayakawa (T)

Pharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, 577-8502, Japan.

Hiroyuki Moriyama (H)

Pharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, 577-8502, Japan. moriyama@phar.kindai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH